Mezrich Joshua D, Kesselheim Jared A, Johnston Douglas R, Yamada Kazuhiko, Sachs David H, Madsen Joren C
Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Transplant. 2003 Sep;3(9):1107-15. doi: 10.1046/j.1600-6143.2003.00202.x.
To determine the mechanism by which cotransplantation of a kidney allograft induces tolerance to a donor heart in miniature swine, we examined the role of CD25+ cells in heart/kidney recipients. Tolerance was induced to class-I MHC mismatched hearts by cotransplanting a donor-specific kidney with a 12-day course of cyclosporine. Peripheral blood leukocytes (PBL) were isolated from tolerant heart/kidney recipients and used in cell-mediated lympholysis (CML) coculture assays as either unmodified PBL, PBL enriched for CD25+ cells or PBL depleted of CD25+ cells to assess their ability to suppress CML responses of naïve recipient-matched leukocytes against mismatched target cells. Primed PBL from tolerant heart/kidney recipients completely suppressed lysis by naïve cells. Complete suppression of the response of naïve recipient-matched leukocytes against donor-matched target cells was lost following the depletion of CD25+ cells from tolerant heart/kidney animal PBL, but it was reestablished by incubation of naïve cells with small populations of CD25+ cells from tolerant heart/kidney animals. These data suggest that peripheral blood from tolerant heart/kidney recipients contains regulatory cells that, upon priming, can suppress the response of naïve-matched PBL in coculture CML assays, and that suppression appears to be dependent on cells expressing CD25.
为了确定同种异体肾移植诱导小型猪对供体心脏产生耐受的机制,我们研究了CD25+细胞在心脏/肾脏联合移植受者中的作用。通过将供体特异性肾脏与为期12天的环孢素联合移植,诱导对I类主要组织相容性复合体(MHC)不匹配的心脏产生耐受。从耐受的心脏/肾脏联合移植受者中分离外周血白细胞(PBL),并将其用于细胞介导的淋巴细胞溶解(CML)共培养试验,分别作为未修饰的PBL、富含CD25+细胞的PBL或去除CD25+细胞的PBL,以评估它们抑制未致敏的受体匹配白细胞对不匹配靶细胞的CML反应的能力。来自耐受的心脏/肾脏联合移植受者的致敏PBL完全抑制了未致敏细胞的溶解作用。从耐受的心脏/肾脏联合移植动物的PBL中去除CD25+细胞后,未致敏的受体匹配白细胞对供体匹配靶细胞的反应的完全抑制作用丧失,但通过将未致敏细胞与来自耐受的心脏/肾脏联合移植动物的少量CD25+细胞一起孵育,这种抑制作用得以重建。这些数据表明,来自耐受的心脏/肾脏联合移植受者的外周血含有调节性细胞,在致敏后,这些细胞可以在共培养CML试验中抑制未致敏的匹配PBL的反应,并且这种抑制作用似乎依赖于表达CD25的细胞。